OPEN-SOURCE SCRIPT
Half-Pi Cycle CKB top indicator (insanely experimental)

This is an insanely experimental script. It's a modified version of the Bitcoin pi-cycle top indicator.
It changes the Bitcoin pi-cycle top formula by halving the number of days in the two DMAs used in calculation, from 350/111 to 175/56. So I call it the half-pi cycle. It correctly picked the top of CKB (Nervos Network) vs USDT on Huobi in spring 2021 within three days.
It probably is a coincidence, and could very easily not pick the next cycle peak correctly at all. Using such a short number of days makes it a little dubious, but I had no choice since there's only so much price history for this coin. I strongly advise you to not make any trades based on this script! I cannot be held accountable if you lose money due to this script. It hasn't been shown to be accurate multiple times like the Bitcoin pi-cycle top indicator. I simply find this interesting and want to see if it works next time.
It changes the Bitcoin pi-cycle top formula by halving the number of days in the two DMAs used in calculation, from 350/111 to 175/56. So I call it the half-pi cycle. It correctly picked the top of CKB (Nervos Network) vs USDT on Huobi in spring 2021 within three days.
It probably is a coincidence, and could very easily not pick the next cycle peak correctly at all. Using such a short number of days makes it a little dubious, but I had no choice since there's only so much price history for this coin. I strongly advise you to not make any trades based on this script! I cannot be held accountable if you lose money due to this script. It hasn't been shown to be accurate multiple times like the Bitcoin pi-cycle top indicator. I simply find this interesting and want to see if it works next time.
开源脚本
秉承TradingView的精神,该脚本的作者将其开源,以便交易者可以查看和验证其功能。向作者致敬!您可以免费使用该脚本,但请记住,重新发布代码须遵守我们的网站规则。
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
开源脚本
秉承TradingView的精神,该脚本的作者将其开源,以便交易者可以查看和验证其功能。向作者致敬!您可以免费使用该脚本,但请记住,重新发布代码须遵守我们的网站规则。
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。